Skip to content

Screening of lipid biomarkers for sepsis based on lipomic strategy

Screening of lipid biomarkers for sepsis based on lipomic strategy

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200059128
Enrollment
Unknown
Registered
2022-04-25
Start date
2019-09-01
Completion date
Unknown
Last updated
2024-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis

Interventions

case series:none

Sponsors

Shanxi Bethune Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 82 Years

Inclusion criteria

Inclusion criteria: Patients who met the diagnostic criteria for sepsis (refer to the definition of Sepsis 3.0 published in 2016) and who met the requirements for venous blood collection within 24 hours of admission to the ICU.

Exclusion criteria

Exclusion criteria: 1. Patients and subjects who aged < 18 years, refuse to participate or do not provide informed consent. 2. Pregnant and lactating patients and children. 3. Patients with other serious cardiovascular diseases. 4. Patients with other mental diseases or low cooperation in the treatment process. 5. Patients with tumors or immune defects that have a greater impact on immunity. 6. Long-term use of hormone drugs or other drugs that affect the experimental data.

Design outcomes

Primary

MeasureTime frame
Lipid metabolites;

Secondary

MeasureTime frame
Indicators of infection;Patient disease severity score;Indicators of organ function;

Countries

China

Contacts

Public ContactWu Weidong

Shanxi Bethune Hospital

13503545010@163.com+86 13503545010

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026